Research Topics
| Christian RouxSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluorideV Abitbol
Service de Gastroenterologie, Hopital Cochin, Paris, France, INSERM U444, UNIVERSITE DE PARIS, Paris, France
Aliment Pharmacol Ther 16:919-27. 2002..Previous data have indicated low bone formation as a mechanism of osteoporosis in inflammatory bowel disease. Fluoride can stimulate bone formation...
The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal womenJ Fechtenbaum
Department of Rheumatology, Descartes University of Paris Faculty of Medicine, , 27 rue du Faubourg Saint Jacques, 75014, Paris, France
Osteoporos Int 16:2175-9. 2005..Treating women with prevalent fractures may avoid a further decrease in their quality of life...
[Prevention and treatment of steroid-induced osteoporosis]C Roux
, , , , Service de Rhumatologie, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
Ann Endocrinol (Paris) 67:162-5. 2006
Inverse relationship between vertebral fractures and spine osteoarthritis in postmenopausal women with osteoporosisC Roux
Paris Descartes University, Cochin Hospital, Rheumatology Department, 27, rue du Faubourg St Jacques 75014 Paris, France
Ann Rheum Dis 67:224-8. 2008..The aim of this study was to check this hypothesis in postmenopausal women with osteoporosis...
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussionC Roux
Cochin Hospital, Rheumatology Department, Paris Descartes University, Paris, France
Curr Med Res Opin 24:1363-70. 2008..In addition to vitamin D and calcium, treatment of patients with osteoporosis at high risk of fractures should also include pharmacologic agents with proven vertebral and non-vertebral fracture efficacy...
Impact of treatments for osteoporosis on osteoarthritis progressionC Roux
Assistance Publique Hopitaux de Paris, Hopital Cochin, Service de Rhumatologie, Universite Paris Descartes, 75014, Paris, France
Osteoporos Int 23:S881-3. 2012..Appropriate identification of patients at high risk of developing cartilage deterioration is a key issue for the analysis of impact of treatments for osteoporosis on osteoarthritis progression...
Monitoring of bone turnover markers does not improve persistence with ibandronate treatmentChristian Roux
Service de Rhumatologie, Paris Descartes University, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
Joint Bone Spine 79:389-92. 2012..To assess if the use of biological marker of bone resorption (CTX) feedback is a mean to improve persistence on monthly oral ibandronate...
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisC Roux
Rheumatology Department, Paris Descartes University, Hopital Cochin, 27 rue du Faubourg Saint Jacques, 75679 Paris Cedex 14, France
Osteoporos Int 23:1083-90. 2012..Conclusions This post hoc analysis suggests that zoledronic acid is significantly more effective than risedronate in increasing LS BMD in prevention and treatment of glucocorticoid-induced osteoporosis across a wide range of patients...
[Vertebral fractures]Christian Roux
Universite Paris Descartes, Faculte de Medecine, AP HP, Hopital Cochin, Service de Rhumatologie, 75014 Paris
Rev Prat 62:181-5. 2012..They are a strong risk factor for sustaining other fractures, including hip fractures. There is a high level of evidence for efficacy of antiosteoporotic treatments in post-menopausal patients with osteoporosis and vertebral fractures...
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosisF E Cotté
CERMES, IFR69, INSERM U750, National Institute of Health and Medical Research, Villejuif, France
Osteoporos Int 21:145-55. 2010..Better control of fracture risk may thus be achieved using monthly treatment regimens...
Osteoporosis in inflammatory joint diseasesC Roux
Rheumatology Department, Cochin Hospital, Paris Descartes University, Paris, France
Osteoporos Int 22:421-33. 2011..However, AS is characterized by progressive stiffness and ankylosis of the spine and illustrates also the potential role of inflammation on local bone formation...
[Management of osteoporosis: room for improvment]Christian Roux
Hopital Cochin, 27, rue du Faubourg St Jacques, 75679 Paris Cedex 14
Bull Acad Natl Med 194:1483-8; discussion 1488-91. 2010..Several drugs have shown that they are able to decrease the risk of fracture, providing persistence and compliance. Non pharmacological approach (including nutrition and physical activity) is part of optimal management of osteoporosis...
Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosisC Roux
Departement de Rhumatologie, AP HP Hôpital Cochin, University Paris Descartes, Paris 75014, France
Ann Rheum Dis 67:1736-8. 2008..Strontium ranelate efficacy against vertebral fractures is presently assessed in a subset of women aged 50-65 years...
Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU studyC Roux
Department of Rheumatology, Paris Descartes University, Cochin Hospital, Paris, France
Osteoporos Int 22:1227-36. 2011..Almost 40% of patients had a previous fracture, while 25% had neither fracture nor dual energy X-ray absorptiometry (DXA) diagnosis and were prescribed medication, probably due to other risk factors...
Increase in vertebral fracture risk in postmenopausal women using omeprazoleChristian Roux
Rheumatology Department, AP HP Cochin Hospital, Paris Descartes University, 27 rue Faubourg Saint Jacques, Paris 75014, France
Calcif Tissue Int 84:13-9. 2009..Further studies are required to determine the mechanism of the association between the underlying gastric disease, omeprazole use, and risk of osteoporotic fractures...
Severe osteoporosis: diagnosis and follow-up. Lessons for clinical practiceChristian Roux
Service de Rhumatologie B, Universite Paris Descartes, Hopital Cochin, Paris, France
Joint Bone Spine 77:S139-41. 2010..This statement was validated by a panel of 70 French rheumatologists at the first national ODISSEE meeting held on November 13-14, 2009...
[Osteoporosis]Christian Roux
Service de Rhumatologie, , , 75014 Paris
Rev Prat 56:673-7. 2006
Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitorsC Roux
Department of Rheumatology, AP HP Cochin Hospital, Paris Descartes University, 27 rue Faubourg Saint Jacques, Paris 75014, France
Osteoporos Int 23:277-84. 2012..The results of our post hoc analysis showed that, regardless of PPI concomitant use, risedronate significantly reduced the risk of new vertebral fractures compared with placebo...
Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosisChristian Roux
Paris Descartes University, Cochin Hospital, Rheumatology Department, Paris, France
J Bone Miner Res 25:362-8. 2010..Thoracic kyphosis progression over three years is lower in a subgroup of strontium ranelate-treated patients compared with placebo-treated patients...
Prevalence of risk factors for referring post-menopausal women for bone densitometry. The INSTANT studyChristian Roux
Rheumatology Department, Paris Descartes University, Cochin Hospital, Paris, France
Joint Bone Spine 75:702-7. 2008..Measurement of bone density by densitometry is an appropriate public health strategy for prevention of osteoporotic fractures in at-risk individuals, and physicians are encouraged to screen for these risk factors in post-menopausal women...
How long should patients take medications for postmenopausal osteoporosis?Karine Briot
Rheumatology Department, Paris Descartes University, School of Medecine, 75014 Paris, France
Joint Bone Spine 74:24-31. 2007..Thus, 4 years may be appropriate for anti-resorptive drug therapy. However, the optimal treatment duration should be determined on a case-by-case basis according to the results of regular fracture-risk evaluations...
[Drug treatment of postmenopausal osteoporosis. What's New in 2006]Christian Roux
Service de Rhumatologie, , Paris (75
Presse Med 35:1529-39. 2006
Bone status in primary hyperparathyroidism assessed by regional bone mineral density from the whole body scan and QUS imaging at calcaneusChristine Chappard
Service de Physiologie et Radio isotopes, Hopital Europeen Georges Pompidou, Paris, France
Joint Bone Spine 73:86-94. 2006..Indeed, the distal part of the limbs are the most affected areas in PHPT whatever the amount of cortical or trabecular bone...
[Vitamin D: skeletal and extra skeletal effects; recommendations for good practice]Karine Briot
Service de Rhumatologie, Hopital Cochin, F 75679 Paris cedex 14, France
Presse Med 38:43-54. 2009..and the measurement of the serum 25OHD level is the only way to determine the vitamin D status. It is recommended to measure the serum 25OHD level in patients with osteoporosis or at risk of osteoporosis, and to correct the deficiency...
A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel diseaseVered Abitbol
Assistance Publique Hopitaux de Paris, Gastroenterologie, Hopital Cochin, Paris, France
Clin Gastroenterol Hepatol 5:1184-9. 2007..Our aim was to assess the efficacy of intravenous clodronate in preventing steroid-induced bone loss...
Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatmentKarine Briot
Paris Descartes University, Medicine Faculty, Cochin Hospital, Paris, France
J Rheumatol 35:855-61. 2008..To determine the changes in body weight, body composition, and bone density in patients with spondyloarthropathy (SpA) receiving anti-tumor necrosis factor-alpha (TNF-alpha) treatment...
Injection of intra-articular sodium hyaluronidate (Sinovial) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis. A prospective evaluation of efficacyChristian Roux
University Hospital l Archet 1, Rheumatology Department, CHU Nice, France
Joint Bone Spine 74:368-72. 2007..To compare the efficacy on pain relief and function of one, two or three injections of intra-articular hyaluronic acid in symptomatic osteoarthritis (OA) of the carpometacarpal joint of the thumb (CMCJ)...
Influence of vertebral fracture assessment by dual-energy X-ray absorptiometry on decision-making in osteoporosis: a structured vignette surveyChristian Roux
Rheumatology Department, Paris Descartes University, Paris, France
Rheumatology (Oxford) 50:2264-9. 2011..This study was designed to assess the impact of VFA results on decision-marking in osteoporosis, using a clinical vignette-based approach...
Prevalence and features of osteoporosis in the French general population: the Instant studyEric Lespessailles
Rheumatology Department, Orléans University Hospital, 45000 Orléans, France
Joint Bone Spine 76:394-400. 2009..To determine the prevalence of diagnosed osteoporosis, the extent of treatment use and the incidence of fracture in a representative sample of the French general population...
Male osteoporosis: diagnosis and fracture risk evaluationKarine Briot
Service de Rhumatologie, Hopital Cochin, 27 rue du Faubourg St Jacques, 75014 Paris, France
Joint Bone Spine 76:129-33. 2009..The identification of men at high risk for fractures requires a combined evaluation of bone mineral density data, clinical risk factors, and risk factors for falls...
Diagnosis of vertebral fractures by vertebral fracture assessmentJoel Damiano
Service de Rhumatologie, Universite Paris Descartes, Faculte de Medecine, Assistance Publique Hopitaux de Paris, Hopital Cochin, Paris, France
J Clin Densitom 9:66-71. 2006..VFA is a reliable technique with low radiation, and is easily and rapidly applicable during bone density measurement by DXA, which could improve management of osteoporotic patients...
Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?Martin Soubrier
Service de Rhumatologie, Hopital G Montpied, Clermont Ferrand, France
J Rheumatol 33:1243-6. 2006..To determine in clinical practice which clinical status variables for rheumatoid arthritis (RA) are most closely associated with a change in disease modifying antirheumatic drug (DMARD) therapy...
Calcium intake and the risk of osteoporosis and fractures in French womenPatrice Fardellone
INSERM ERI 12, Service de Rhumatologie, Amiens University Hospital, CHU Nord, Place Victor Pauchet, 80054 Amiens cedex 01, France
Joint Bone Spine 77:154-8. 2010..To evaluate dietary calcium intake in postmenopausal women over 45 years of age and compare intake according to osteoporosis diagnosis and fracture history...
Severe osteoporosis: does structural monitoring help?Ariane Leboime
Universite Paris Descartes, Hopital Cochin, Service de Rhumatologie B, 27 rue du Faubourg Saint Jacques, Paris, France
Joint Bone Spine 77:S113-6. 2010..VFA used in conjunction with absorptiometry may be well suited to the monitoring of women with severe osteoporosis...
Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone scoreSophie Breban
Department of Rheumatology, Paris Descartes University, Cochin Hospital, Paris, France
J Clin Densitom 15:260-6. 2012..In this population, at low risk according to BMD, TBS could help to detect patients with VF...
Hip cortical thickness assessment in postmenopausal women with osteoporosis and strontium ranelate effect on hip geometryKarine Briot
Rheumatology Department, Cochin Hospital, Paris Descartes University, Paris, France
J Clin Densitom 15:176-85. 2012..Some HSA parameters have predictive value for hip fracture risk in postmenopausal osteoporotic women. Strontium ranelate improves some HSA parameters, through the BMD increase...
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factorsChristian Roux
Universite Paris Descartes, Faculte de Medecine, Assistance Publique Hopitaux de Paris, Hopital Cochin, Service de Rhumatologie, Paris, France
J Bone Miner Res 21:536-42. 2006..Strontium ranelate (2 g/day) was studied in 5082 postmenopausal women. A reduction in incident vertebral fracture risk by 40% was shown after 3 years. This effect was independent of age, initial BMD, and prevalent vertebral fractures...
Assessment of non-vertebral fracture risk in postmenopausal womenChristian Roux
Universite Paris Descartes, Faculte de Medecine, Assistance Publique Hopitaux de Paris, Hopital Cochin, Service de Rhumatologie, Paris 75014, France
Ann Rheum Dis 66:931-5. 2007..Non-vertebral (NV) fractures are responsible for a great amount of morbidity, mortality and cost attributable to osteoporosis...
Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null miceLaurence Nicolet-Barousse
Departement de Physiologie, Hôpital Européen George Pompidou, Institut National de la Santé et de la Recherche Médicale INSERM U 652, IFR 58, Universite Paris V, Paris, France
J Bone Miner Res 20:799-808. 2005....
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosisKarine Briot
Service de Rhumatologie, Hopital Cochin, Universite Paris Descartes, Paris, France
Joint Bone Spine 79:304-13. 2012....
Efficacy of risedronate on clinical vertebral fractures within six monthsChristian Roux
Cochin Hospital, Rene Descartes University, Paris, France
Curr Med Res Opin 20:433-9. 2004..Risedronate has been shown to reduce the incidence of radiographically-defined vertebral fractures by approximately two-thirds within 1 year...
Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndromeHang Korng Ea
Rheumatology Department, Rene Descartes University, France
J Rheumatol 32:1840-2. 2005..Additionally, the association between GS (NCCT inactivation) and high bone mineral density provides a new insight into the possible role of thiazides in osteoporosis management...
Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathyKarine Briot
Faculte de Medecine, Universite Paris Descartes, UPRES EA 4058, Hopital Cochin, Paris, France
J Rheumatol 35:310-4. 2008..We describe the effects of etanercept on biochemical markers of type II collagen synthesis and degradation in patients with SpA followed for 2 years...
Osteoporosis and mortalityAriane Leboime
Service de Rhumatologie B, Universite Paris Descartes, Hopital Cochin, 27 rue du Faubourg Saint Jacques, Paris, France
Joint Bone Spine 77:S107-12. 2010..Here, we will review the main data linking osteoporotic fractures overall (as opposed to hip fractures only) and mortality...
Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120)Sylvie Rozenberg
AP HP, Groupe Hospitalier Pitie Salpetriere, Service de Rhumatologie, Paris, France
AIDS Res Hum Retroviruses 28:972-80. 2012..1% (95% CI 2.8 to 9.3); p=0.0003]. Alendronate 70 mg weekly for 96 weeks improves BMD in HIV-1-infected patients on antiretroviral therapy...
Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosisChristian Roux
Groupe de Recherche et d Information sur les Ostéoporoses Task Force for Research and Information on Osteoporosis, Hopital Cochin, 27, rue du Faubourg St Jacques, 75014, Paris, France
Joint Bone Spine 72:26-31. 2005..Biochemical markers for bone turnover can be monitored after only 3-6 months provided steps are taken to control for intraindividual variability. They are useful when patient compliance is poor or the treatment response inadequate...
Practice patterns in outpatient rheumatology: a pilot evaluation of medical file contentJacques Fechtenbaum
Rheumatology Department B, Cochin Teaching Hospital, AP HP, and René Descartes Paris V University, Paris, France
Joint Bone Spine 74:171-4. 2007..Subsequently, one of the RHEVER members investigated whether these recommendations were followed by RHEVER participants at a teaching hospital...
Accuracy of patient-reported height loss and risk factors for height loss among postmenopausal womenKarine Briot
Department of Rheumatology, Hôpital Cochin and Université Paris Descartes, Paris, France
CMAJ 182:558-62. 2010..We undertook this study to compare reported and measured loss of height among post-menopausal women in a primary care setting. We also analyzed the determinants of this height loss...
Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective studyVeronique Forin
Service d Orthopédie Pédiatrique, Hopital Armand Trousseau, Assistance Publique Hopitaux de Paris, Universite Paris VI, Paris, France
Joint Bone Spine 72:313-8. 2005..To study the efficacy of pamidronate in children with osteogenesis imperfecta (OI)...
Serum leptin as a determinant of bone resorption in healthy postmenopausal womenChristian Roux
Centre d Evaluation des Maladies Osseuses, Departement de Rhumatologie, Hopital Cochin AP HP, Universite Rene Descartes, Paris, France
Bone 33:847-52. 2003..In conclusion, leptin may play a role as a determinant of bone resorption in healthy, untreated postmenopausal women, but the effect of estradiol or tibolone on bone are not mediated by leptin...
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patientsMaxime Dougados
Paris Descartes University, Medicine Faculty, Rheumatology B Department, Paris 14, France
Joint Bone Spine 78:598-603. 2011....
Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic reviewThomas Funck-Brentano
Paris Descartes University, Cochin Hospital, Department of Rheumatology B, Paris, France
Semin Arthritis Rheum 41:157-69. 2011....
What is the role of DXA, QUS and bone markers in fracture prediction, treatment allocation and monitoring?Karine Briot
Departement de Rhumatologie, Hopital Cochin, 27 rue du Faubourg St Jacques, 75014 Paris, France
Best Pract Res Clin Rheumatol 19:951-64. 2005..Biochemical markers of bone remodelling can be useful for both prediction of fracture risk and monitoring of treatment if sources of variability are controlled...
Drug-induced osteoporosis: beyond glucocorticoidsKarine Briot
Department of Rheumatology, Cochin Hospital, 27 rue du Faubourg St Jacques, 75014 Paris, France
Curr Rheumatol Rep 10:102-9. 2008..Strong evidence points to gonadotropin-releasing hormone agonists, aromatase inhibitors, and antiepileptic drugs. Further studies are necessary to confirm the deleterious effect of other treatments on bone...
One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trialH Fernandez
Service de Gynecologie Obstetrique, Hopital Antoine Beclere, AP HP, 92141 Clamart, Paris, France
Hum Reprod 19:1465-71. 2004..The optimal combination for long-term treatments with safe metabolic profile remains questionable. A norprogesterone derivative, promegestone, was assessed for the first time in a double-blind trial...
Discrimination of osteoporotic patients with quantitative ultrasound using imaging or non-imaging deviceGeraldine Falgarone
Centre d Evaluation des Maladies Osseuses, Institut de Rhumatologie, Hopital Cochin, Universite Rene Descartes, 27, rue du Faubourg St Jacques, 75014 Paris, France
Joint Bone Spine 71:419-23. 2004..The aim of this study was to compare the clinical utility of QUS parameters measured using imaging and non-imaging devices in the discrimination of osteoporotic patients...
[Osteoporosis and hormone replacement therapy]Christian Roux
Service de Rhumatologie, Universite Rene Descartes, Hopital Cochin, 27, rue du Faubourg, St Jacques, 75014 Paris
Presse Med 34:379-84. 2005..The menopause is the occasion to assess individual risks, notably vascular and of fractures, taking into account the clinical risk factors and measurement of bone density...
Bone mineral measurements in mice: comparison of two devicesSami Kolta
Rheumatology Department, Cochin Hospital, Assistance Publique, , Paris, France
J Clin Densitom 6:251-8. 2003..We concluded that bone density and bone-density changes in mice can be measured precisely in vivo using the Hologic and Piximus devices; the latter being able to measure the whole body BMD with good precision...
[Non-invasive method for measuring bone mineral density]Christian Roux
Centre d Evaluation des Maladies Osseuses, Institut de Rhumatologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
Med Sci (Paris) 19:231-8. 2003..Thus, therapeutic decision is based on both BMD and clinical risk factors that contribute to fracture risk...
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registryD Salmon-Ceron
Service de Rhumatologie, Hopital Bicetre, 78 rue du General Leclerc, 94275 Le Kremlin Bicetre
Ann Rheum Dis 70:616-23. 2011..Anti-tumour necrosis factor (TNF) therapy may be associated with opportunistic infections (OIs)...
In vivo 3D reconstruction of human vertebrae with the three-dimensional X-ray absorptiometry (3D-XA) methodS Kolta
Paris Descartes University, Medicine Faculty, UPRES EA 4058, AP HP, Cochin Hospital, Paris, France
Osteoporos Int 19:185-92. 2008..This new technique, called 3D-XA (three-dimensional X-ray absorptiometry), allows the direct measurement of geometric parameters of the vertebrae with a good accuracy and precision...
Systemic mastocytosis and bone involvement in a cohort of 75 patientsS Barete
AP HP, Dermatology and Allergy Department, Universite Pierre et Marie Curie, Tenon Hospital, 4 rue Chine, Paris 75020, France
Ann Rheum Dis 69:1838-41. 2010..To investigate bone involvement in a large cohort of systemic mastocytosis (SM) patients, and evaluate the efficacy of bisphosphonate therapy. Patients and..
Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature reviewA Ruyssen Witrand
Rheumatology B Department, Paris Rene Descartes University, Medicine Faculty AP HP, Cochin Hospital, Paris, France
Osteoporos Int 18:1271-8. 2007..Analysis showed that patients with vertebral fractures have smaller non-fractured vertebrae than patients without fractures. Vertebral size is an independent risk factor of vertebral fractures...
Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosisC Roux
Rheumatology Department, Paris Descartes University, Cochin Hospital, Paris, France
Rheumatology (Oxford) 47:iv20-22. 2008..During these clinical trials, safety was good. Its large spectrum of efficacy allows the use of strontium ranelate in the different subgroups of patients with post-menopausal osteoporosis...
Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experienceK Briot
Paris Descartes University, Rheumatology Department Cochin Hospital, Paris, France
Osteoporos Int 20:625-30. 2009..Analysis showed that the persistence rate was 81.5% for women who follow the program, higher than for existing oral antiresorptive treatments...
[Osteoporosis and the orthopaedic surgeon in 2007]J M Feron
Service de Chirurgie Orthopedique et Traumatologique, Hopital Saint Antoine, AP HP, Universite Pierre et Marie Curie Paris VI, 184, rue du Faubourg Saint Antoine, 75012 Paris, France
Rev Chir Orthop Reparatrice Appar Mot 94:S99-107. 2008..This round table highlights the current aspect of management of fragility fractures and focuses on diagnosis imaging techniques, pharmacological treatment as well as recent advances in implant design and surgical techniques...
Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fracturesF Grados
Department of Rheumatology, CHU Amiens, France
Osteoporos Int 12:716-22. 2001..The SQ approach that allows differential diagnosis of vertebral deformities and has demonstrated a better reproducibility can be employed alone when it is performed by experienced and well-trained readers...
A clinical tool to determine the necessity of spine radiography in postmenopausal women with osteoporosis presenting with back painC Roux
Universite Paris Descartes, Hopital Cochin, Paris, France
Ann Rheum Dis 66:81-5. 2007..In a population of postmenopausal women with osteoporosis and back pain, symptoms may be related to vertebral fractures or degenerative changes of the spine...
Septic knee arthritis after intra-articular hyaluronate injection. Two case reportsChristine Albert
Rheumatology Department, Archet 1 Teaching Hospital, CHU de Nice, 151 rte St Antoine de Ginestiére, BP 3079, 06202 Nice Cedex 3, France
Joint Bone Spine 73:205-7. 2006..Faultless aseptic technique is essential when administering hyaluronate viscosupplementation. Patients should be informed of the risk of septic arthritis...
Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) studyKarine Briot
Rheumatology Department, Cochin Hospital, Rheumatology Department, Paris Descartes University, 27 rue Faubourg Saint Jacques, 75014, Paris, France
Breast Cancer Res Treat 120:127-34. 2010..04). This study shows that in patients intolerant to one AI, switching to another agent allows a higher proportion of patients to continue the therapy and maximize hormonal adjuvant therapy and disease outcome benefits...
Segmentation of quantitative ultrasonographic images of the calcaneus using elastic deformation of the flexible Fourier contourPascal Laugier
Laboratoire d Imagerie Parametrique, Unite Mixte de Recherche, Centre National de la Recherche Scientifique 7623, Universite Paris VI, Paris, France
J Ultrasound Med 23:693-9. 2004..This study investigated a new technique for automatic model-based segmentation of broadband ultrasound attenuation (BUA) images of the calcaneus. We determined whether this technique was able to improve osteoporotic fracture discrimination...
Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancerMirieme Ghazi
Pairs Descartes University, Rheumatology Department, Cochin Hospital, Paris, France
Best Pract Res Clin Rheumatol 23:805-11. 2009..A comprehensive assessment of risk of fractures must be performed at the initiation of an AI therapy. Antiresorptive drugs (i.e., bisphosphonates and denosumab) are effective for bone loss prevention and treatment in these patients...
[Paget's disease, workup and monitoring]Christian Roux
Institut de Rhumatologie, Hôpital Cochin Université René Descartes, 27, rue du Faubourg St Jacques, Paris
Presse Med 34:608-11. 2005..Total alkaline phosphatase is the best marker and measurement of collagen breakdown products is useful in difficult cases. The goal of treatment is the normalization of these biological markers, to prevent complications of the disease...
[Diagnosis of osteoporosis]Christian Roux
Service de Rhumatologie, Hopital Cochin, 75014 Paris
Rev Prat 54:2107-19. 2004..Osteoporosis may be related to malignant and metabolic diseases, which must be checked before any treatment...
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatmentK Briot
Hopital Cochin, Departement de Rhumatologie, 27 rue du Faubourg St Jacques, 75014 Paris, France
Ann Rheum Dis 64:1137-40. 2005..To determine the changes in body weight, body composition, and bone turnover in patients with spondyloarthropathy (SpA) treated with anti-tumour necrosis factor alpha (TNFalpha)...
Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized studyB Cortet
Rheumatology Department, Lille Teaching Hospital, France
Rev Rhum Engl Ed 66:214-9. 1999..Etidronate prevents glucocorticoid-induced lumbar spine bone loss in patients with rheumatoid arthritis, polymyalgia rheumatica, or giant cell arteritis...
Reporting of vertebral fractures on spine X-raysJ Fechtenbaum
Department of Rheumatology, Paris 5 University AP-HP Cochin Hospital, 27 rue du Faubourg, Saint Jacques, 75014, Paris, France
Osteoporos Int 16:1823-6. 2005..As a consequence, patients who require treatment to reduce fracture risk are not being properly identified...
Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone lossC Roux
Centre d Evaluation des Maladies Osseuses, Departement de Rhumatologie, Hopital Cochin, Universite Rene Descartes, Paris, France
Osteoporos Int 13:241-8. 2002..7% and 2.6%, respectively). Each treatment effectively prevented bone loss. Overall, tolerability of tibolone was better than with E2/NETA, because of less frequent vaginal bleeding and breast pain. This may promote long-term adherence...
Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS studyF Grados
Department of Rheumatology, Centre Hospitalier Universitaire, Amiens, France
Bone 34:362-7. 2004..105, P = 0.004). We conclude that the prevalence of vertebral fractures is high in French ambulatory elderly women, which confirms the results of previous studies conducted in various Caucasian and Asian populations...
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritisF Chopin
INSERM U890, Rheumatology Department, University Hospital of St Etienne, France
Ann Rheum Dis 67:353-7. 2008..Therefore, we tested the hypothesis that administration of infliximab, an anti-TNFalpha drug in the treatment of RA, would modulate systemic and local bone resorption and reduce cartilage degradation...
Mild prevalent and incident vertebral fractures are risk factors for new fracturesC Roux
Cochin Hospital, Rheumatology Department, University of Paris, 27, rue du Faubourg St Jacques, 75014, Paris, France
Osteoporos Int 18:1617-24. 2007..This prospective four-year study indicates that post-menopausal osteoporotic women with mild prevalent and incident vertebral fractures have an increased risk of incident fractures...
Statins in rheumatologyMartin Soubrier
Rheumatology Department, G Montpied Hospital, Place H Dunant, BP 69, 63003 Clermont Ferrand, France
Joint Bone Spine 73:159-68. 2006..When these show dyslipidemia, statin therapy should be started according to current recommendations...
Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthmaChristian Roux
Hopital Cochin, Assistance Publique Hopitaux de Paris, Universite Rene Descartes, Paris, France
Pediatrics 111:e706-13. 2003..Inhaled corticosteroids are recommended as first-line therapy for pediatric asthma. However, few controlled long-term studies have investigated their effect on bone mineral density (BMD) and growth...
Increase in vertebral body size in postmenopausal women with osteoporosisK Briot
Paris Descartes University, Rheumatology Department, Cochin Hospital, Paris, France
Bone 47:229-34. 2010..01). These prospective results demonstrate that vertebral body dimensions increase over 3 years in women with postmenopausal osteoporosis...
[Steroid induced osteoporosis: prevention and treatment]C Roux
Institut de Rhumatologie, Hopital Cochin, Centre d Evaluation des Maladies Osseuses, 27, rue du Faubourg Saint Jacques, 75014, Paris, France
Rev Med Interne 24:384-8. 2003..New data from biological, epidemiological and therapeutic studies provide basis for optimal management of this bone disease...
[Postmenopausal osteoporosis: current treatment]C Roux
Service de Rhumatologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
Rev Med Interne 25:S568-72. 2004..Based on anti fracture efficacy of treatments, it is relevant to assess post menopausal women for the risk of osteoporotic fractures, based on clinical risk factors and bone mineral density measurements...
Three-dimensional X-ray absorptiometry (3D-XA): a method for reconstruction of human bones using a dual X-ray absorptiometry deviceS Kolta
Rheumatology Department, Cochin Hospital, Assistance Publique, Hôpitaux de Paris Université René Descartes, Paris, France
Osteoporos Int 16:969-76. 2005..It has good accuracy and reproducibility in the present study on cadaveric femurs. In vivo prospective studies are needed to evaluate its discriminating potential on hip fracture risk prediction...
Spinal deformity index (SDI) is a good predictor of incident vertebral fracturesS Kerkeni
Cochin Hospital, Rheumatology Department, Paris Descartes University, Paris, France
Osteoporos Int 20:1547-52. 2009..It is a predictor of the risk of sustaining incident vertebral fracture. This quantification must be taken into account to improve management of patients...
Bone mineral density assessment using the EOS low-dose X-ray device: a feasibility studyE Sapin
Laboratoire de Biomecanique, LBM, Arts et Metier ParisTech, CNRS, Paris, France
Proc Inst Mech Eng H 222:1263-71. 2008..The reproducibility of the method of assessment is equal to 0.95 per cent. The EOS system is accurate for ex-vivo BMD assessments, which is promising regarding the use of this new system to predict vertebral strength...
Ultrasonic backscatter and transmission parameters at the os calcis in postmenopausal osteoporosisC Roux
, Hĵpital Cochin, , Paris, France
J Bone Miner Res 16:1353-62. 2001..However, BUB evaluation, which does not require two transducers and may be implemented in conventional reflection mode systems, warrants further studies...
Quantitative ultrasound in postmenopausal osteoporosisC Roux
Centre d Evaluation des Maladies Osseuses, Departement de Rhumatologie, Hopital Cochin, Universite Rene Descartes, Paris, France
Curr Opin Rheumatol 12:336-45. 2000..Monitoring of skeletal changes and treatment effects by ultrasound cannot be recommended...
Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up studyJ F Maillefert
Department of Rheumatology, Dijon University Hospital, France
Osteoporos Int 12:605-9. 2001..1% +/- 5.7 and -1.2% +/- 3.9 in patients with and without persistent inflammation; respectively; p = 0.007). These results suggest that persistent inflammation might be an etiologic factor of bone loss in AS...
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alphaF Allali
Rheumatology Department, , Cochin Hospital, Paris, France
Ann Rheum Dis 62:347-9. 2003..35, p=0.06). CONCLUSION: These data suggest that a benefit of anti-tumour necrosis factor alpha therapy on BMD in patients with SpA may be through an uncoupling effect on bone cells...
Predictors of compliance with a home-based exercise program added to usual medical care in preventing postmenopausal osteoporosis: an 18-month prospective studyM A Mayoux-Benhamou
Rehabilitation Department, Cochin Hospital, Assistance Publique Hopitaux de Paris, Rene Descartes University, F 75014 Paris Cedex, France
Osteoporos Int 16:325-31. 2005..10 to 1.16). Despite the addition of an educational session to usual medical care to inform participants about the benefits of exercise, only a minority of postmenopausal women adhered to a home-based exercise program after 18 months...
Management of osteoporosis: a physiological answer for a living tissue. IntroductionC Roux
Rheumatology Department, Paris Descartes University, Cochin Hospital, Paris, France
Rheumatology (Oxford) 47:iv1. 2008
Short-term protein and energy supplementation activates nitrogen kinetics and accretion in poorly nourished elderly subjectsC Bos
Institut National de la Recherche Agronomique INRA, Unité de Nutrition Humaine et de Physiologie Intestinale, Institut National Agronomique Paris Grignon INA PG, Paris, France
Am J Clin Nutr 71:1129-37. 2000..However, there are few data on the response to such dietary changes in malnourished elderly subjects, despite important medical implications in this population...
The long-term effectiveness of preventive strategies for osteoporosis in postmenopausal women: a modeling approachC Le Pen
University Paris Dauphine, Paris, France
Osteoporos Int 11:524-32. 2000..5-2.1% decrease in all fractures. The combined strategies, S5 and S6, produce intermediate results: a 12.9-13.5% reduction in the number of all fractures and a 17.5-17.9% reduction in hip fractures...
Calcitonin in glucocorticoid-induced osteoporosisC Roux
Departement de Rhumatologie, , , Paris, France
Front Horm Res 30:145-9. 2002
Infliximab in spondylarthropathy--influence on bone densityE Demis
Rheumatology Department, , Cochin Hospital, Paris, France
Clin Exp Rheumatol 20:S185-6. 2002..There was an increase in osteocalcin between baseline and week 6. These data suggest a benefit of anti-TNFalpha therapy on BMD in patients with SpA, may be through an uncoupling effect on bone cells...
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective studyA Arabi
Centre d'Evaluation des Maladies Osseuses, , , , Paris, France
Hum Reprod 18:1747-52. 2003....
Ultrasound measurement on the calcaneus: influence of immersion time and rotation of the footC Chappard
Laboratoire d Imagerie Parametrique, URA 1452 CNRS, Paris, France
Osteoporos Int 9:318-26. 1999..The coefficients of variation were 1.1% for BUA and 0.1% for SOS in premenopausal women, and 1.4% for BUA and 0.13% for SOS in postmenopausal women...
